|By PR Newswire||
|February 28, 2014 05:17 AM EST||
DUBLIN, Feb. 28, 2014 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/xd4dc6/cancer_test) has announced the addition of the "Concise Analysis of the International Cancer Test Market" report to their offering.
Cancer is the second-leading cause of death and disability in the world, behind only heart disease. More people die from cancer every year around the world than AIDS, Tuberculosis and Malaria combined. Cancer testing has tremendous growth opportunities for the next five years. According to the National Cancer Institute (NCI), 85% of cancer patients are treated in community-based, private practice oncology settings. Accordingly, global expansion of cancer marker technologies may be fueled by an increased marketing of new diagnostic tests to physicians.
During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. The anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The global cancer test market is expected to be more than US$ 14 Billion by 2018.
This study provides a comprehensive assessment of the fast-evolving, high-growth of Cancer Test market segment. This page report with 52 Figures and 57 Tables studies the Cancer Test Platform of 20 Companies. This report is broadly divided into 8 chapters.
Key Topics Covered:
Table of Contents
1. Executive Summary
2. Global - Cancer Testing Market and New Cases
3. Global - Cancer Testing Market Share
4. Global - Segment Wise Cancer Testing Market
5. Global - Organ Specific Cancer Testing Market
6. Cancer Diagnostics- Companies Novel Test Platforms & Pipeline Analysis (20 Companies Analysis)
- BD Diagnostics
- Beckman Coulter
- Genomic Health
- Myriad Genetics
- Panacea Pharmaceuticals
- QIAGEN Marseille (Earlier Ipsogen)
- Radient Pharmaceuticals
- Siemens Heathcare Diagnostics
- Ventana Medical Systems
For more information visit http://www.researchandmarkets.com/research/xd4dc6/cancer_test
Media Contact: Laura Wood , +353-1-481-1716, [email protected]
Chris Van Tuin, Chief Technologist for the Western US at Red Hat, has over 20 years of experience in IT and Software. Since joining Red Hat in 2005, he has been architecting solutions for strategic customers and partners with a focus on emerging technologies including IaaS, PaaS, and DevOps. He started his career at Intel in IT and Managed Hosting followed by leadership roles in services and sales engineering at Loudcloud and Linux startups.
Oct. 8, 2015 07:00 PM EDT Reads: 152
Oct. 8, 2015 07:00 PM EDT
Containers are revolutionizing the way we deploy and maintain our infrastructures, but monitoring and troubleshooting in a containerized environment can still be painful and impractical. Understanding even basic resource usage is difficult - let alone tracking network connections or malicious activity. In his session at DevOps Summit, Gianluca Borello, Sr. Software Engineer at Sysdig, will cover the current state of the art for container monitoring and visibility, including pros / cons and li...
Oct. 8, 2015 07:00 PM EDT Reads: 173
Between the compelling mockups and specs produced by analysts, and resulting applications built by developers, there exists a gulf where projects fail, costs spiral, and applications disappoint. Methodologies like Agile attempt to address this with intensified communication, with partial success but many limitations. In his session at DevOps Summit, Charles Kendrick, CTO and Chief Architect at Isomorphic Software, will present a revolutionary model enabled by new technologies. Learn how busine...
Oct. 8, 2015 06:45 PM EDT Reads: 248
IT data is typically silo'd by the various tools in place. Unifying all the log, metric and event data in one analytics platform stops finger pointing and provides the end-to-end correlation. Logs, metrics and custom event data can be joined to tell the holistic story of your software and operations. For example, users can correlate code deploys to system performance to application error codes.
Oct. 8, 2015 06:45 PM EDT Reads: 196
Oct. 8, 2015 06:30 PM EDT Reads: 154
There are so many tools and techniques for data analytics that even for a data scientist the choices, possible systems, and even the types of data can be daunting. In his session at @ThingsExpo, Chris Harrold, Global CTO for Big Data Solutions for EMC Corporation, will show how to perform a simple, but meaningful analysis of social sentiment data using freely available tools that take only minutes to download and install. Participants will get the download information, scripts, and complete en...
Oct. 8, 2015 06:15 PM EDT Reads: 248
Today’s connected world is moving from devices towards things, what this means is that by using increasingly low cost sensors embedded in devices we can create many new use cases. These span across use cases in cities, vehicles, home, offices, factories, retail environments, worksites, health, logistics, and health. These use cases rely on ubiquitous connectivity and generate massive amounts of data at scale. These technologies enable new business opportunities, ways to optimize and automate, al...
Oct. 8, 2015 06:15 PM EDT Reads: 128
Oct. 8, 2015 06:00 PM EDT Reads: 779
Oct. 8, 2015 06:00 PM EDT Reads: 132
Oct. 8, 2015 06:00 PM EDT Reads: 223
Oct. 8, 2015 06:00 PM EDT Reads: 2,157
Oct. 8, 2015 06:00 PM EDT Reads: 1,067
Oct. 8, 2015 06:00 PM EDT Reads: 377